Metraipolis › archive › dc_f950f5207fb2

When should RWE studies be prioritized for reimbursement? Insights from the Canadian perspective — Europe PMC PMID:41508412

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41508412
DOI
10.1017/s0266462325103401
License (as archived)
solo-consultazione
Archived
2026-11-06T22:35:53.609Z
SHA-256 of the archived text
77b0df8502c7ba92e28427ba1664472281aae5e3a546eac84a72e21307aa7084
Stable URL of this page
https://metraipolis.com/documento/dc_f950f5207fb2

How to cite

When should RWE studies be prioritized for reimbursement? Insights from the Canadian perspective — Europe PMC PMID:41508412 — Europe PMC (en), https://europepmc.org/article/MED/41508412 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f950f5207fb2 (Metraipolis archive dc_f950f5207fb2, sha256 77b0df8502c7ba92e28427ba1664472281aae5e3a546eac84a72e21307aa7084)
BibTeX
@misc{dcf950f5207fb2,
  title = {When should RWE studies be prioritized for reimbursement? Insights from the Canadian perspective — Europe PMC PMID:41508412},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41508412},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f950f5207fb2; sha256 77b0df8502c7ba92e28427ba1664472281aae5e3a546eac84a72e21307aa7084},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41508412. Agents can read the archived copy with the MCP tool read_document.